Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Luvu Brands (LUVU) is “One to Watch”

Luvu Brands (OTCQB: LUVU) is a Georgia-based manufacturer that produces a range of products in the wellness, lifestyle, and casual furniture categories. The company is made up of over 135 employees and emphasizes creativity throughout its business. LUVU products are sold in innovative eco-compressed vacuum packaging for all its retailers worldwide. In addition to offering […]

eXp World Holdings, Inc. (EXPI) Real Estate Buyer/Seller Cloud Environment Offers Refreshing Alternative to Process Complexities

Agent-owned cloud brokerage firm eXp World Holdings, Inc. (OTCQB: EXPI) builds shareholder value by leveraging the use of cloud technology in one of the most entrenched industries of our age. The company’s business model understands that buyers and sellers of real estate have at their disposal more knowledge than they’ve ever had before. With the […]

Moxian, Inc. (MOXC) Using Gamification to Boost Business Results

Moxian, Inc. (OTCQB: MOXC) is a multi-national company that is committed to building a comprehensive solution using promotional platforms and social marketing to help businesses grow through social media. MOXC’s products enable other merchants to target their marketing, advertising campaigns, and promotional tools to their audiences by using data put together through the Moxian database. […]

International Stem Cell Corp. (ISCO) Advancing Clinical Development Program for Parkinson’s Disease

International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with parthenogenesis to treat diseases of the eyes, the nervous system, the liver, and more. Currently, ISCO is preparing for a phase I clinical trial of its proprietary human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC®) for the treatment of Parkinson’s disease (PD), […]

eXp World Holdings, Inc. (EXPI) CEO Scheduled to Speak at Mendix World in the Netherlands

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that Glenn Sanford, the company’s founder and chief executive officer, has been invited to present at Mendix World, a two-day conference focused on strategic technology trends, digital transformation and insight into integrating technology with business. Mendix, the titular sponsor of the event, is a cloud-based, platform […]

Alternet Systems, Inc. (ALYI) is a Fintech with a Future

The financial tech, or “fintech,” phenomenon is changing the landscape of financial services. Traditional ways of providing financial services such as making payments, accepting deposits, and lending and risk management are being abandoned as new channels, made possible by digital technology, are opened up. Technological innovation hasn’t just given rise to a new type of […]

International Stem Cell Corp. (ISCO) Publishes Results from Preclinical Study of ISC-hpNSC® for Treatment of Parkinson’s Disease

Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced the publication of results from a 12-month preclinical, non-human primate study. The data highlights the safety and efficacy of ISCO’s proprietary human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC®) for the treatment of Parkinson’s disease. According to the results of this study, transplantation of […]

Rennova Health, Inc.’s (RNVA) Focus on Compliance and Provider Contracts Reflects Background of Executive Team

Rennova Health, Inc. (NASDAQ: RNVA), Florida-based provider of technologies and services to the healthcare industry, has successfully faced a number of industry-wide challenges in recent years due to the steadfast focus on strict compliance by its executive team and the resulting potential that approach offers toward expanding provider contracts. It’s an accomplishment based upon a […]

 

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

May 13, 2025

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies […]

Rotate your device 90° to view site.